Colrain Capital LLC Bristol Myers Squibb CO Transaction History
Colrain Capital LLC
- $99.1 Million
- Q4 2024
A detailed history of Colrain Capital LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Colrain Capital LLC holds 121,500 shares of BMY stock, worth $6.82 Million. This represents 6.93% of its overall portfolio holdings.
Number of Shares
121,500Holding current value
$6.82 Million% of portfolio
6.93%Shares
1 transactions
Others Institutions Holding BMY
# of Institutions
2,671Shares Held
1.47BCall Options Held
31.9MPut Options Held
35.3M-
Vanguard Group Inc Valley Forge, PA190MShares$10.7 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.91 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.39 Billion0.44% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.22 Billion0.2% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.39 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $119B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...